\-\ Texto\\:\\ \ \(0\)\
\-\ chest\\ exam\\:\\ diffuse\\ decreased\\ breath\\ sounds\\ with\\ associated\\ diffuse\\ wheezing\\.\\ \\ \ \(0\)\
\-\ labs\\:\\ elevated\\ hepatic\\ enzymes\\.\ \(0\)\
\-\ patient\\ listed\\ for\\ liver\\ transplant\ \(0\)\
\-\ abdominal\\ ct\\ demonstrates\\ a\\ nodular\\ hepatic\\ contour\\.\\ \\ cxr\\ reveals\\ hyperinflated\\ lungs\\.\\ \\ chest\\ ct\\ reveals\\ basilar\\-predominant\\ hyperlucent\\ lungs\\ with\\ significant\\ oligemia\\.\\ \\ nuclear\\ medicine\\ v\\/q\\ scans\\ demonstrate\\ patchy\\ pulmonary\\ perfusion\\ and\\ basilar\\-predominant\\ air\\ trapping\\ on\\ xenon\\ washout\\ imaging\\.\ \(0\)\
\-\ alpha\\ 1\\-antitrypsin\\ \\(serum\\ trypsin\\ inhibitor\\)\\ deficiency\ \(0\)\
\-\ swyer\\-james\\ \\(post\\-viral\\)\\ syndrome\ \(0\)\
\-\ toxic\\ inhalation\\ \\(toxic\\ liver\\ injury\\)\ \(0\)\
\-\ genetic\\ syndrome\\ \\(a1at\\ deficiency\\)\ \(0\)\
\-\ pulmonary\\/hepatic\\ venoocclusive\\ disease\ \(0\)\
\-\ 44\\-yo\\ female\\ with\\ progressive\\ shortness\\ of\\ breath\\ and\\ ruq\\ abdominal\\ pain\\.\\ \\ she\\ denies\\ smoking\\,\\ alcohol\\ use\\,\\ and\\ has\\ no\\ history\\ to\\ suggest\\ pneumoconiosis\\ or\\ other\\ explanation\\ for\\ progressive\\ shortness\\ of\\ breath\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ basilar\\-predominant\\:\\ 0\\.1399288638724841\ \(0\)\
\-\ toxic\\:\\ 0\\.07950564974914569\ \(0\)\
\-\ breath\\:\\ 0\\.07607422757736543\ \(0\)\
\-\ deficiency\\:\\ 0\\.07318771118373861\ \(0\)\
\-\ xenon\\:\\ 0\\.06996443193624205\ \(0\)\
\-\ 1\\-antitrypsin\\:\\ 0\\.06996443193624205\ \(0\)\
\-\ trypsin\\:\\ 0\\.06996443193624205\ \(0\)\
\-\ post\\-viral\\:\\ 0\\.06996443193624205\ \(0\)\
\-\ a1at\\:\\ 0\\.06996443193624205\ \(0\)\
\-\ pulmonary\\/hepatic\\:\\ 0\\.06996443193624205\ \(0\)\
\-\ 44\\-yo\\:\\ 0\\.06996443193624205\ \(0\)\
\-\ venoocclusive\\:\\ 0\\.06446326383655994\ \(0\)\
\-\ swyer\\-james\\:\\ 0\\.058962095736877836\ \(0\)\
\-\ shortness\\:\\ 0\\.05706607299822497\ \(0\)\
\-\ hepatic\\:\\ 0\\.056642767488984315\ \(0\)\
\-\ oligemia\\:\\ 0\\.05574411868840034\ \(0\)\
\-\ progressive\\:\\ 0\\.05361014468322702\ \(0\)\
\-\ hyperinflated\\:\\ 0\\.053460927637195725\ \(0\)\
\-\ reveals\\:\\ 0\\.05306742460785751\ \(0\)\
\-\ hyperlucent\\:\\ 0\\.05252614163992284\ \(0\)\
\-\ inhalation\\:\\ 0\\.05252614163992284\ \(0\)\
\-\ lungs\\:\\ 0\\.051361723777464695\ \(0\)\
\-\ v\\/q\\:\\ 0\\.05093351707276292\ \(0\)\
\-\ explanation\\:\\ 0\\.05024295058871823\ \(0\)\
\-\ inhibitor\\:\\ 0\\.04847197002273244\ \(0\)\
\-\ pneumoconiosis\\:\\ 0\\.0474786117453197\ \(0\)\
\-\ washout\\:\\ 0\\.04702497354024074\ \(0\)\
\-\ liver\\:\\ 0\\.04676542080686863\ \(0\)\
\-\ alpha\\:\\ 0\\.04543234897308081\ \(0\)\
\-\ listed\\:\\ 0\\.04441779840554204\ \(0\)\
\-\ enzymes\\:\\ 0\\.04410652290432552\ \(0\)\
\-\ trapping\\:\\ 0\\.04410652290432552\ \(0\)\
\-\ diffuse\\:\\ 0\\.04106360984722722\ \(0\)\
\-\ wheezing\\:\\ 0\\.03924061438935403\ \(0\)\
\-\ syndrome\\:\\ 0\\.03879216788467685\ \(0\)\
\-\ perfusion\\:\\ 0\\.038605354804643416\ \(0\)\
\-\ ruq\\:\\ 0\\.03816020030741291\ \(0\)\
\-\ transplant\\:\\ 0\\.03746963382336824\ \(0\)\
\-\ genetic\\:\\ 0\\.03708241029821401\ \(0\)\
\-\ patchy\\:\\ 0\\.036360412058486016\ \(0\)\
\-\ nuclear\\:\\ 0\\.03499046965636702\ \(0\)\
\-\ smoking\\:\\ 0\\.03425165677489074\ \(0\)\
\-\ alcohol\\:\\ 0\\.03416395966229879\ \(0\)\
\-\ abdominal\\:\\ 0\\.0339034799701923\ \(0\)\
\-\ contour\\:\\ 0\\.03287848880559199\ \(0\)\
\-\ serum\\:\\ 0\\.03273151223601075\ \(0\)\
\-\ chest\\:\\ 0\\.032456015873928865\ \(0\)\
\-\ medicine\\:\\ 0\\.03216940070768843\ \(0\)\
\-\ scans\\:\\ 0\\.03158124219853191\ \(0\)\
\-\ suggest\\:\\ 0\\.02888387850311642\ \(0\)\
\-\ cxr\\:\\ 0\\.028619303739087915\ \(0\)\
\-\ denies\\:\\ 0\\.028619303739087915\ \(0\)\
\-\ nodular\\:\\ 0\\.028447696881840567\ \(0\)\
\-\ sounds\\:\\ 0\\.027050370257987136\ \(0\)\
\-\ use\\:\\ 0\\.02680507234161351\ \(0\)\
\-\ labs\\:\\ 0\\.023587095293136014\ \(0\)\
\-\ elevated\\:\\ 0\\.023010447312373512\ \(0\)\
\-\ air\\:\\ 0\\.02294652878215846\ \(0\)\
\-\ \\(\\:\\ 0\\.02293211829345589\ \(0\)\
\-\ \\)\\:\\ 0\\.022651990225819207\ \(0\)\
\-\ injury\\:\\ 0\\.021620702713403172\ \(0\)\
\-\ decreased\\:\\ 0\\.02016473335495682\ \(0\)\
\-\ pulmonary\\:\\ 0\\.019813891350952885\ \(0\)\
\-\ she\\:\\ 0\\.019037985249636288\ \(0\)\
\-\ ct\\:\\ 0\\.01897307386336576\ \(0\)\
\-\ significant\\:\\ 0\\.018236882151223995\ \(0\)\
\-\ \\:\\:\\ 0\\.01794087009508992\ \(0\)\
\-\ associated\\:\\ 0\\.0160036711262516\ \(0\)\
\-\ imaging\\:\\ 0\\.015889474797266687\ \(0\)\
\-\ other\\:\\ 0\\.015632051973828956\ \(0\)\
\-\ demonstrate\\:\\ 0\\.015606763026452704\ \(0\)\
\-\ exam\\:\\ 0\\.014898682063091572\ \(0\)\
\-\ demonstrates\\:\\ 0\\.014814453981374492\ \(0\)\
\-\ female\\:\\ 0\\.013942541836887567\ \(0\)\
\-\ has\\:\\ 0\\.012735714051541887\ \(0\)\
\-\ for\\:\\ 0\\.011573145216551032\ \(0\)\
\-\ disease\\:\\ 0\\.011085218581077017\ \(0\)\
\-\ history\\:\\ 0\\.009366782045294312\ \(0\)\
\-\ pain\\:\\ 0\\.00828260450421218\ \(0\)\
\-\ or\\:\\ 0\\.00794859324574371\ \(0\)\
\-\ no\\:\\ 0\\.006828921830982555\ \(0\)\
\-\ patient\\:\\ 0\\.006798348658066571\ \(0\)\
\-\ on\\:\\ 0\\.0057451667648049844\ \(0\)\
\-\ \\,\\:\\ 0\\.004296985166941069\ \(0\)\
\-\ and\\:\\ 0\\.004285928707909963\ \(0\)\
\-\ to\\:\\ 0\\.003389429432087192\ \(0\)\
\-\ a\\:\\ 0\\.0031476174747508035\ \(0\)\
\-\ with\\:\\ 0\\.0027858137164259457\ \(0\)\
\-\ \\.\\:\\ 0\\.001972196449852571\ \(0\)\
\-\ of\\:\\ 0\\.0018492666793331496\ \(0\)\
